Cargando…
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia
The telomerase RNA component (TERC) gene plays an important role in telomerase-dependent extension and maintenance of the telomeres. In the event of TERC haploinsufficiency, telomere length is often affected; this, in turn, can result in the development of progeria-related diseases such as aplastic...
Autores principales: | Tang, Xinyu, Xu, Ruirong, Wang, Yan, Chen, Kaiqing, Cui, Siyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332096/ https://www.ncbi.nlm.nih.gov/pubmed/37424004 http://dx.doi.org/10.1186/s10020-023-00691-w |
Ejemplares similares
-
Novel therapeutic choices in immune aplastic anemia
por: Scheinberg, Phillip
Publicado: (2020) -
Ginsenoside Rg1 can restore hematopoietic function by inhibiting Bax translocation-mediated mitochondrial apoptosis in aplastic anemia
por: Cao, Huiqin, et al.
Publicado: (2021) -
Functions and regulatory mechanisms of resting hematopoietic stem cells: a promising targeted therapeutic strategy
por: Tang, Xinyu, et al.
Publicado: (2023) -
Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018) -
Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)